Ausdal Financial Partners »

Acelyrin shares owned by Ausdal Financial Partners

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Ausdal Financial Partners from 13F filings

Historical chart of Ausdal Financial Partners investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Ausdal Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Ausdal Financial Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $130k 19k 6.75
2023-12-31 $151k 20k 7.46
2023-09-30 $214k 21k 10.17

More positions owned by Ausdal Financial Partners

Ishares Tr Short Treas Bd (SHV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Caterpillar (CAT)
Ishares Tr Msci Acwi Etf (ACWI)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Microsoft Corporation (MSFT)
Wisdomtree Tr Floatng Rat Trea (USFR)
Ishares Tr Rus 1000 Etf (IWB)

View all positions for Ausdal Financial Partners

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
Opaleye Management
OrbiMed Advisors
venBio Partners
Jpmorgan Chase & Co
Artal Group
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management
Goldman Sachs Group

View all funds holding Acelyrin